Developed by: Realigns Pharmaceuticals.,Co.Ltd Thailand.
Clinical Decision Support Software (CDS)
Licensed physicians, medical officers, and qualified clinical practitioners
Hospitals, clinics, outpatient settings
Sympnotic-AI is a clinical decision support software intended to assist licensed healthcare professionals by providing data-driven clinical reference, structured case discussion, and guideline-based alerts derived exclusively from manufacturer-validated medical datasets.
Sympnotic-AI does not provide autonomous diagnoses, treatment decisions, or prescriptive medical advice. Final clinical judgment and responsibility remain entirely with the healthcare professional.
Sympnotic-AI is designed as a non-authoritative clinical co-pilot that supports clinicians during patient evaluation through structured, stepwise interaction. The system facilitates:
All clinical content presented by the system is derived solely from internally maintained, validated medical datasets owned and controlled by Realigns Pharmaceuticals.,Co. Ltd Thailand.
A large language model (LLM) is used only for:
The LLM is structurally prohibited from:
Conducts stepwise, case-based dialogue aligned with clinical reasoning workflows. Follow-up questions are generated strictly based on dataset-defined symptom and disease relationships.
Identifies high-risk scenarios (“cannot-miss” conditions) exclusively when dataset-defined criteria are met. Alerts are informational and advisory, prompting clinician review rather than directing action.
Highlights abnormal results based on deterministic reference ranges contained within the datasets. No interpretation beyond dataset thresholds is generated.
When medical images are uploaded, the system may provide non-diagnostic contextual observations aligned with dataset references. Image analysis outputs are advisory only and require clinician confirmation.
Sympnotic-AI is designed in alignment with FDA guidance on Clinical Decision Support Software, ensuring that: